Results 271 to 280 of about 3,362,668 (327)

Risk of venous thromboembolism during treatment with antipsychotic agents

Psychiatry and Clinical Neurosciences, 2012
J. Masopust, R. Malý, M. Valis
semanticscholar   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Risk of Death in Dual-eligible Nursing Home Residents Using Typical or Atypical Antipsychotic Agents

Medical Care, 2012
R. Aparasu, S. Chatterjee, S. Mehta, Hua Chen   +3 more
semanticscholar   +1 more source

Antipsychotic Agents (Neuroleptics)

Journal of Clinical Psychopharmacology, 1994
  +4 more sources

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Antipsychotic Agents in the Treatment of Anorexia Nervosa: Neuropsychopharmacologic Rationale and Evidence from Controlled Trials

Current Psychiatry Reports, 2012
T. Brewerton
semanticscholar   +1 more source

[New antipsychotic agents].

La Revue du praticien, 1995
In the eighties, the notions of refractory schizophrenia and of atypical neuroleptics have been described. An "atypical" neuroleptic is an effective antipsychotic drug without inducing concomitant extrapyramidal side effects. The concept of atypicity has become a new vista for research of new antipsychotic drugs.
openaire   +1 more source

Antipsychotic Agents

Burger's Medicinal Chemistry and Drug Discovery
S. Ablordeppey, E. Ofori
semanticscholar   +1 more source

Antipsychotic Agents

2002
openaire   +2 more sources

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly